Training supports multi-site clinical trial of MDMA-assisted Massed Prolonged Exposure Therapy for PTSD in active-duty service ...

New studies show that psychedelics could unlock safer treatments for chronic pain, mood disorders, and even neuroprotection.

The FDA-approved trial in Arizona explores whole-mushroom psilocybin therapy for PTSD with first responders and veterans.

Johns Hopkins trial veteran warns venture capital threatens therapeutic integrity as psilocybin nears FDA approval ...

In a first-of-its-kind study, a team of researchers from the University of California, Davis has examined the effects of psychedelic microdosing on animal behavior. The results yielded a variety of ...

A new clinical trial underway in the Lowcountry is drawing attention for its unconventional — and potentially groundbreaking ...

As it turns out, researching the efficacy of MDMA to treat PTSD may be pretty complicated. The initial efforts to secure governmental sanction for a psychedelic substance for mental health care, in ...

The center will use psychedelics to study the mind and therapies for addiction. Johns Hopkins University is launching a new center for psychedelic research that will use psychedelic drugs to study the ...

Rick Doblin had come to believe that psychedelic experiences are the "common core" of all religions, and he wanted to test this thesis. In February 1984, the 31-year-old college student living off a ...

New Jersey is poised to become one of the first states on the East Coast to establish a regulated framework for ...

For the last five years, my lead chemist, Armando, has developed new products that people with advanced chemistry degrees have assured me are impossible to make. From putting powderized functional ...

The last decade has been inarguably incredible for the field of psychedelic science. The term renaissance is hyperbolically thrown around a lot these days but in this context it is perfectly apt.